| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Clinical Research
1 company
Capps Scott B is a VP, Clinical Research at ARTIVION, INC.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2020 | AORT Artivion, Inc. | VP, Clinical Research | Sale+OE | 8,366 | $21.34 | $178,553.03 | -5.3% | |
| Nov 26, 2019 | AORT Artivion, Inc. | VP, Clinical Research | Sale+OE | 7,184 | $24.93 | $179,107.90 | -4.8% | |
| May 31, 2019 | AORT Artivion, Inc. | VP, Clinical Research | Sell | 2,000 | $28.55 | $57,100.00 | -1.4% | |
| Aug 30, 2018 | AORT Artivion, Inc. | VP, Clinical Research | Sale+OE | 6,332 | $34.10 | $215,921.20 | -4.3% | |
| Feb 22, 2017 | AORT Artivion, Inc. | VP, Clinical Research | Sale+OE | 11,083 | $16.40 | $181,775.61 | -8.6% |